Delivery Order SPE2DE21D0005-SPE2D624F2Z66

Award Date 3/20/24
Potential Completion Date 3/25/24
Potential Value $2.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF, a specialized wound care product. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 27, 2024. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF wound dressings. The award, valued at $2,479.90, has a fixed-price with economic price adjustment pricing type and an ultimate completion date of April 8, 2024. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) awarded by DLA to Organogenesis for wound care...
This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Organogenesis Inc., a leading regenerative medicine company. The order is for $1,239.95 in APLIGRAF wound care products, with a completion date of March 29, 2024. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) that Organogenesis holds with the DLA for wound care dressings, discs, and other medical materials. Organogenesis has also...
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a wound care product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order, which includes an economic price adjustment, has a completion date of June 11, 2024. Organogenesis Inc. is a for-profit manufacturer of goods and has been a registered federal contractor since 2006. The company holds several significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The award, valued at $1,239.95, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle held by Organogenesis with the DLA, valued at $49.5 million, for wound care dressings and medical supplies. This IDC was awarded as a total small...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. The contract has an ultimate completion date of March 10, 2025. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit medical device manufacturer based in Canton, Massachusetts. The contract, valued at $1,239.95, is for the provision of APLIGRAF, a skin substitute product used for advanced wound care. The contract does not have a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis has established itself as a key...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D624F2Z66
    Delivery Order

This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $2,479.90, is for the delivery of APLIGRAF wound care products to the DLA's Medical Supply Chain program. The contract has a period of performance through March 25, 2024 and utilizes a fixed price with economic price adjustment pricing structure. This award is part of a larger $49.5 million indefinite delivery contract (IDC) that Organogenesis holds with DLA for wound care dressings, discs, and other medical materials. Organogenesis also maintains several other federal contracts and agreements to provide its regenerative medicine products, including surgical implants and wound care solutions, to the Department of Veterans Affairs and other government customers. This particular award does not utilize a set-aside designation.

Generated 6/19/24, 9:35 AM